187 related articles for article (PubMed ID: 37527510)
1. Disease Diagnosis Based on Nucleic Acid Modifications.
Xue X; Wang Z; Wang Y; Zhou X
ACS Chem Biol; 2023 Oct; 18(10):2114-2127. PubMed ID: 37527510
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modification of nucleic acids: from basic studies to medical applications.
Chen Y; Hong T; Wang S; Mo J; Tian T; Zhou X
Chem Soc Rev; 2017 May; 46(10):2844-2872. PubMed ID: 28352906
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and Quantitative Analytical Techniques of Nucleic Acid Modification Based on Mass Spectrometry for Biomarker Discovery.
Liu Y; Dong JH; Shen XY; Gu YX; Zhang RH; Cui RY; Liu YH; Zhou J; Zhou YL; Zhang XX
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542356
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas-Based In Vitro Diagnostic Platforms for Cancer Biomarker Detection.
Gong S; Zhang S; Lu F; Pan W; Li N; Tang B
Anal Chem; 2021 Sep; 93(35):11899-11909. PubMed ID: 34427091
[TBL] [Abstract][Full Text] [Related]
5. Interventions targeted at oxidatively generated modifications of nucleic acids focused on urine and plasma markers.
Larsen EL; Weimann A; Poulsen HE
Free Radic Biol Med; 2019 Dec; 145():256-283. PubMed ID: 31563634
[TBL] [Abstract][Full Text] [Related]
6. Detection and Application of 5-Formylcytosine and 5-Formyluracil in DNA.
Wang Y; Zhang X; Zou G; Peng S; Liu C; Zhou X
Acc Chem Res; 2019 Apr; 52(4):1016-1024. PubMed ID: 30666870
[TBL] [Abstract][Full Text] [Related]
7. Analysis of single nucleic acid molecules in micro- and nano-fluidics.
Friedrich SM; Zec HC; Wang TH
Lab Chip; 2016 Mar; 16(5):790-811. PubMed ID: 26818700
[TBL] [Abstract][Full Text] [Related]
8. Functional nucleic acid-based fluorescence polarization/anisotropy biosensors for detection of biomarkers.
Bai Y; Shu T; Su L; Zhang X
Anal Bioanal Chem; 2020 Oct; 412(25):6655-6665. PubMed ID: 32601896
[TBL] [Abstract][Full Text] [Related]
9. Review: Multiplexed profiling of biomarkers in extracellular vesicles for cancer diagnosis and therapy monitoring.
Zhou S; Yang Y; Wu Y; Liu S
Anal Chim Acta; 2021 Aug; 1175():338633. PubMed ID: 34330441
[TBL] [Abstract][Full Text] [Related]
10. SWAMNA: a comprehensive platform for analysis of nucleic acid modifications.
Xie Y; De Luna Vitorino FN; Chen Y; Lempiäinen JK; Zhao C; Steinbock RT; Lin Z; Liu X; Zahn E; Garcia AL; Weitzman MD; Garcia BA
Chem Commun (Camb); 2023 Oct; 59(83):12499-12502. PubMed ID: 37786919
[TBL] [Abstract][Full Text] [Related]
11. Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology.
Amalric A; Bastide A; Attina A; Choquet A; Vialaret J; Lehmann S; David A; Hirtz C
Crit Rev Clin Lab Sci; 2022 Jan; 59(1):1-18. PubMed ID: 34473579
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid-based marker approaches to urologic cancers.
Veltri RW; Makarov DV
Urol Oncol; 2006; 24(6):510-27. PubMed ID: 17138133
[TBL] [Abstract][Full Text] [Related]
13. Extracellular nucleic acids and their potential as diagnostic, prognostic and predictive biomarkers.
O'Driscoll L
Anticancer Res; 2007; 27(3A):1257-65. PubMed ID: 17593617
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of disease relevant nucleic acid biomarkers with off-the-shelf devices.
Qi L; Du Y
J Mater Chem B; 2022 Jun; 10(21):3959-3973. PubMed ID: 35575030
[TBL] [Abstract][Full Text] [Related]
15. Advances in Electrochemical Biosensor Technologies for the Detection of Nucleic Acid Breast Cancer Biomarkers.
Chiorcea-Paquim AM
Sensors (Basel); 2023 Apr; 23(8):. PubMed ID: 37112468
[TBL] [Abstract][Full Text] [Related]
16. Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.
Chen C; Yang Z; Tang X
Med Res Rev; 2018 May; 38(3):829-869. PubMed ID: 29315675
[TBL] [Abstract][Full Text] [Related]
17. Capillary electrophoresis based on the nucleic acid detection in the application of cancer diagnosis and therapy.
Lian DS; Zhao SJ
Analyst; 2014 Jul; 139(14):3492-506. PubMed ID: 24872166
[TBL] [Abstract][Full Text] [Related]
18. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics.
Mehan MR; Ostroff R; Wilcox SK; Steele F; Schneider D; Jarvis TC; Baird GS; Gold L; Janjic N
Adv Exp Med Biol; 2013; 735():283-300. PubMed ID: 23402035
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles and their nucleic acids for biomarker discovery.
Momen-Heravi F; Getting SJ; Moschos SA
Pharmacol Ther; 2018 Dec; 192():170-187. PubMed ID: 30081050
[TBL] [Abstract][Full Text] [Related]
20. Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine.
Rahat B; Ali T; Sapehia D; Mahajan A; Kaur J
Front Genet; 2020; 11():844. PubMed ID: 32849827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
